Update on the Management of Vitiligo

Authors

Amanda F Nahhas, Beaumont Health Resident
Taylor L Braunberger
Iltefat H Hamzavi

Document Type

Article

Publication Date

5-1-2019

Publication Title

Skin Therapy Letter

Abstract

Vitiligo is an acquired, autoimmune disease characterized by depigmented macules and patches on the skin, which occur secondary to melanocyte destruction. Available therapeutic options are broadly divided into medical, surgical and phototherapy, though treatment of vitiligo can be challenging. Early diagnosis and management can maximize treatment efficacy. The purpose of this discussion is to review updates in the management of vitiligo, including existing and emerging therapies.

Volume

24

Issue

3

First Page

1

Last Page

6

Recommended Citation

Nahhas AF, Braunberger TL, Hamzavi IH. Update on the Management of Vitiligo. Skin Therapy Lett. 2019 May;24(3):1-6. PMID: 31095346.

ISSN

1201-5989

PubMed ID

31095346